Expression of mammary derived growth inhibitor (MDGI) results in phenotypic reversal in breast cancer

2008 ◽  
Vol 6 (9) ◽  
pp. 38
Author(s):  
J. Nevo ◽  
E. Mattila ◽  
T. Pellinen ◽  
D.L. Yamamoto ◽  
H. Sara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Growth Inhibitor ◽  
Phenotypic Reversal

scholarly journals FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer

2006 ◽  
Vol 120 (5) ◽  
pp. 1013-1022 ◽  
Author(s):  
Ido Wolf ◽  
Shikha Bose ◽  
Elizabeth A. Williamson ◽  
Carl W. Miller ◽  
Beth Y. Karlan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prognostic Factor ◽  
Human Breast Cancer ◽  
Growth Inhibitor ◽  
Human Breast ◽  
Favorable Prognostic Factor

scholarly journals Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells

2006 ◽  
Vol 66 (21) ◽  
pp. 10269-10273 ◽  
Author(s):  
Mahvash Zakikhani ◽  
Ryan Dowling ◽  
I. George Fantus ◽  
Nahum Sonenberg ◽  
Michael Pollak
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Growth Inhibitor ◽  
Amp Kinase ◽  
Dependent Growth

Metformin is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells

2007 ◽  
Vol 62 (3) ◽  
pp. 182-183 ◽  
Author(s):  
Mahvash Zakikhani ◽  
Ryan Dowling ◽  
I George Fantus ◽  
Nahum Sonenberg ◽  
Michael Pollak
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Growth Inhibitor ◽  
Amp Kinase ◽  
Dependent Growth
Sign in / Sign up

Export Citation Format

Share Document